are there long term effects of semaglutide Semaglutide: What we know about safety and cancer risk Semaglutide: Double-edged Sword with Risks

The improvement in HbA1c was twice as large in patients who, during observation, lost 5% or more their initial body weight than in those who did not ( 0.9% vs 0.5%

Remember to report any suspected adverse reactions to either medication via the MHRA Yellow Card Scheme (yellowcard.mhra.gov.uk)

10.1111/j.1476-5381.2009.00441.x [DOI] [PMC free article] [PubMed] [Google Scholar] Coskun T, Sloop KW, Loghin C, Alsina-Fernandez J, Urva S, Bokvist KB, Cui X, Briere DA, Cabrera O, Roell WC, Kuchibhotla U, Moyers JS, Benson CT, Gimeno RE, DAlessio DA, Haupt A (2018) LY3298176, a novel dual GIP and GLP-1 receptor agonist for the treatment of type 2 diabetes mellitus: from discovery to clinical proof of concept

Still, as the authors themselves note, causality cannot be established from this type of dataset

As long as the drug is on the shortage list (Section 506E), the essentially a copy restriction is suspended